Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China · Delayed Price · Currency is CNY 7.26
+0.01 (0.14%)
Feb 4, 2026, 3:04 PM CST
SHE:002107 Revenue
In the year 2025, Shandong Wohua Pharmaceutical had annual revenue of 816.95M CNY with 6.96% growth. Shandong Wohua Pharmaceutical had revenue of 192.34M in the quarter ending December 31, 2025, with 2.79% growth.
Revenue
816.95M
Revenue Growth
+6.96%
P/S Ratio
5.12
Revenue / Employee
802.51K
Employees
1,018
Market Cap
4.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.95M | 53.16M | 6.96% |
| Dec 31, 2024 | 763.79M | -145.71M | -16.02% |
| Dec 31, 2023 | 909.51M | -105.31M | -10.38% |
| Jan 1, 2023 | 1.01B | 72.14M | 7.65% |
| Jan 1, 2022 | 942.67M | -63.41M | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Huaren Pharmaceutical | 1.26B |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Sinotherapeutics | 480.48M |